|
Market Closed -
NYSE
23:00:03 30/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 61.99 USD | -1.46% |
|
-1.37% | -3.47% |
Company Valuation: Dolby Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 9,375 | 6,589 | 7,494 | 7,231 | 6,938 | 5,807 | - | - |
| Change | - | -29.72% | 13.74% | -3.51% | -4.05% | -16.31% | - | - |
| Enterprise Value (EV) | 8,103 | 5,772 | 7,494 | 7,231 | 6,938 | 5,807 | 5,807 | 5,807 |
| Change | - | -28.77% | 29.85% | -3.51% | -4.05% | -16.31% | 0% | 0% |
| P/E | 31.1x | 37.3x | 38.2x | 28.2x | 27.6x | 20x | 17.5x | 16.8x |
| PBR | 3.6x | 2.88x | - | - | 2.65x | 2.22x | - | - |
| PEG | - | -1x | 2.9x | 0.9x | -10.61x | 1.1x | 1.2x | 4.11x |
| Capitalization / Revenue | 7.32x | 5.26x | 5.77x | 5.68x | 5.14x | 4.07x | 3.96x | 3.78x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 4.07x | 3.96x | 3.78x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 10.6x | 10.2x | 9.35x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 19.2x | 17.1x | 14.3x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 16.2x | 12x | 10.8x |
| FCF Yield | 4.2% | 4.11% | 4.49% | 4.11% | 6.28% | 6.18% | 8.34% | 9.29% |
| Dividend per Share 2 | 0.91 | 1.02 | 1.11 | - | 1.32 | - | - | - |
| Rate of return | 0.98% | 1.51% | 1.42% | - | 1.82% | - | - | - |
| EPS 2 | 2.97 | 1.81 | 2.05 | 2.69 | 2.62 | 3.092 | 3.545 | 3.69 |
| Distribution rate | 30.6% | 56.4% | 54.1% | - | 50.4% | - | - | - |
| Net sales 1 | 1,281 | 1,254 | 1,300 | 1,274 | 1,349 | 1,426 | 1,467 | 1,535 |
| EBITDA 1 | 550.2 | 420.6 | 463.9 | 460.1 | 496.3 | 547.1 | 569.6 | 621.2 |
| EBIT 1 | 344.4 | 206.6 | 215.8 | 258.3 | 265 | 302.5 | 339.2 | 404.7 |
| Net income 1 | 310.2 | 184.1 | 200.7 | 261.8 | 255 | 255.7 | 292.3 | 349 |
| Net Debt | -1,272 | -817.6 | - | - | - | - | - | - |
| Reference price 2 | 92.47 | 67.46 | 78.36 | 75.84 | 72.39 | 61.99 | 61.99 | 61.99 |
| Nbr of stocks (in thousands) | 101,387 | 97,677 | 95,641 | 95,348 | 95,844 | 93,669 | - | - |
| Announcement Date | 11/16/21 A | 11/17/22 A | 11/16/23 A | 11/19/24 A | 11/18/25 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 20.05x | - | - | - | 5.81B | ||
| 26.23x | 9.77x | 15.83x | 0.75% | 3,876B | ||
| 118.48x | 52.39x | 85.4x | -.--% | 442B | ||
| 19.59x | 5.66x | 9.85x | 1.53% | 396B | ||
| 232.13x | 20.7x | 60.61x | -.--% | 300B | ||
| 29.22x | 5.98x | 18.57x | 1.27% | 272B | ||
| 2504.3x | 41.91x | 137.1x | -.--% | 257B | ||
| 73.17x | 6.72x | 17.61x | -.--% | 109B | ||
| 42.17x | 11.66x | 29.9x | -.--% | 99.98B | ||
| 13.72x | 3.65x | 7.63x | -.--% | 97.39B | ||
| Average | 307.91x | 17.60x | 42.50x | 0.39% | 585.54B | |
| Weighted average by Cap. | 153.11x | 14.39x | 28.57x | 0.66% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- DLB Stock
- Valuation Dolby Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
















